Tradestie Institutional Equity Comparison Engine
BMRA vs DCTH โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
DCTH Overall Edge
DCTH Captures Institutional Edge (4โ0 Pillars ยท 7โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Delcath Systems Inc (DCTH) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, BMRA trades at N/M Forward P/E with -125.2% operating margin (-8.3% YoY revenue) versus DCTH at N/M Forward P/E and 5.2% operating margin (+70.7% YoY). In options structure, BMRA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against DCTH sits in BREAKOUT (43rd %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
DCTH
BMRA N/M vs DCTH N/M Fwd P/E
Growth & Margin Winner
DCTH
Op Margin -125.2% vs 5.2% ยท YoY -8.3% vs +70.7%
Momentum & Technical Winner
DCTH
1Y -45.6% vs +128.6% ยท 52W Pos 5% vs 80%
Options & Structure Winner
DCTH
UNCLASSIFIED (N/A IV) vs BREAKOUT (43rd %ile IV)
BMRA
NASDAQ
Biomerica Inc
In Vitro & In Vivo Diagnostic Substances
$1.36
+0.0% 1D
Market Cap
$6.0M
1M Return
-26.49%
1Y Return
-45.6%
Forward P/E
N/M
Unified AI Score
44.5 / 100
HOLD
Tech 40.0
Fund 47.0
Flow 50.0
Mom 44.0
DCTH
NASDAQ
Delcath Systems Inc
Surgical & Medical Instruments & Apparatus
$19.68
-4.23% 1D
Market Cap
$743.8M
1M Return
+39.77%
1Y Return
+128.57%
Forward P/E
N/M
Unified AI Score
35.9 / 100
SELL
Tech 50.0
Fund 38.0
Flow 60.0
Mom 54.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
BMRA -45.6%
DCTH +128.57%
Spread: +174.17 pp (DCTH Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | BMRA Revenue | DCTH Revenue | BMRA Op. Margin | DCTH Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | $10M | N/A | -46.4% | N/A | BMRA |
| FY2020 | $10M | N/A | -41.0% | N/A | BMRA |
| FY2021 | $10M | $0M | -104.2% | -690.0% | BMRA |
| FY2022 | $20M | $0M | -24.0% | -1245.1% | BMRA |
| FY2023 | $10M | $0M | -135.3% | -1849.0% | BMRA |
| FY2024 | $10M | $40M | -117.6% | -33.4% | DCTH |
| FY2025 | $10M | $90M | -96.7% | 0.8% | DCTH |
| FY2026 | $0M | N/A | -119.5% | N/A | BMRA |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BMRA | DCTH | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $6.0M | $743.8M | Larger Scale | DCTH |
| Trailing P/E Ratio Valuation | N/M | 133.6x | Lower Multiple | DCTH |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -8.3% | +70.7% | Higher Growth | DCTH |
| Operating Margin (TTM) Profitability | -125.2% | 5.2% | Higher Margin | DCTH |
| Net Profit Margin Profitability | -115.5% | 6.0% | Higher Margin | DCTH |
| Return on Equity (ROE) Capital Efficiency | -113.8% | 5.4% | Higher ROE | DCTH |
| 52-Week Range Position Momentum | 5% ($1โ$3) | 80% ($8โ$23) | Stronger Trend | DCTH |
| Beta / 30D Volatility Risk Regime | 0.67ฮฒ ยท 62% Vol | 1.63ฮฒ ยท 131% Vol | Lower Realized Risk | BMRA |
| Unified Institutional Score Composite Signal | 44.5 / 100 (HOLD) | 35.9 / 100 (SELL) | Higher Composite | BMRA |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full BMRA vs DCTH Buy Guide
BMRA
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
DCTH
BREAKOUT
66d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
43rd %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither BMRA nor DCTH registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.